Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,099 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetics of pantoprazole in man.
Huber R, Hartmann M, Bliesath H, Lühmann R, Steinijans VW, Zech K. Huber R, et al. Int J Clin Pharmacol Ther. 1996 May;34(5):185-94. Int J Clin Pharmacol Ther. 1996. PMID: 8738854 Clinical Trial.
Comparison of the pharmacodynamics and pharmacokinetics of pantoprazole (40 mg) as compared to omeprazole MUPS (20 mg) after repeated oral dose administration.
Ehrlich A, Lücker PW, Wiedemann A, Sander P, Huber R, Mascher H. Ehrlich A, et al. Methods Find Exp Clin Pharmacol. 1999 Jan-Feb;21(1):47-51. doi: 10.1358/mf.1999.21.1.527018. Methods Find Exp Clin Pharmacol. 1999. PMID: 10222447 Clinical Trial.
Pharmacokinetics of pantoprazole in patients with end-stage renal failure.
Kliem V, Bahlmann J, Hartmann M, Huber R, Lühmann R, Wurst W. Kliem V, et al. Nephrol Dial Transplant. 1998 May;13(5):1189-93. doi: 10.1093/ndt/13.5.1189. Nephrol Dial Transplant. 1998. PMID: 9623552
Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.
Simon B, Müller P, Hartmann M, Bliesath H, Lühmann R, Huber R, Bohnenkamp W, Wurst W. Simon B, et al. Z Gastroenterol. 1990 Sep;28(9):443-7. Z Gastroenterol. 1990. PMID: 2177296
No influence of pantoprazole on the pharmacokinetics of phenytoin.
Middle MV, Müller FO, Schall R, Groenewoud G, Hundt HK, Huber R, Bliesath H, Steinijans VW. Middle MV, et al. Int J Clin Pharmacol Ther. 1995 May;33(5):304-7. Int J Clin Pharmacol Ther. 1995. PMID: 7655771 Clinical Trial.
[Pharmacokinetics of the antirheumatic lonazolac-Ca in humans].
Huber R, Zech K, Dittmann EC, Lühmann R, Petitet A. Huber R, et al. Arzneimittelforschung. 1990 Aug;40(8):918-25. Arzneimittelforschung. 1990. PMID: 2242085 German.
Soraprazan: setting new standards in inhibition of gastric acid secretion.
Simon WA, Herrmann M, Klein T, Shin JM, Huber R, Senn-Bilfinger J, Postius S. Simon WA, et al. J Pharmacol Exp Ther. 2007 Jun;321(3):866-74. doi: 10.1124/jpet.107.120428. Epub 2007 Mar 16. J Pharmacol Exp Ther. 2007. PMID: 17369284
No influence of pantoprazole on the pharmacokinetics of phenytoin.
Middle MV, Müller FO, Schall R, Groenewoud G, Hundt HK, Huber R, Bliesath H, Steinijans VW. Middle MV, et al. Int J Clin Pharmacol Ther. 1996 May;34(1 Suppl):S72-5. Int J Clin Pharmacol Ther. 1996. PMID: 8793606 Clinical Trial.
Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B, Müller P, Marinis E, Lühmann R, Huber R, Hartmann R, Wurst W. Simon B, et al. Aliment Pharmacol Ther. 1990 Aug;4(4):373-9. doi: 10.1111/j.1365-2036.1990.tb00483.x. Aliment Pharmacol Ther. 1990. PMID: 2151747 Clinical Trial.
2,099 results
Jump to page
Feedback